Lululemon and Ulta Beauty are the companies in question. Analyst Anna Andreeva said that “based on our store checks, LULU and ULTA were the busiest stores,” noting that Lululemon’s broad discounting ...

In his "Cassandra Unchained" blog post published Sunday, Burry estimated that Tesla dilutes its shareholders at approximately 3.6% per year without conducting any buybacks. He warned that CEO Elon ...

American Tower is now projected to post 2% AFFO per share growth in 2026 versus the Street at 6.1%. Barclays cut its price target to $200, based on 17 times projected 2027 AFFO, and highlighted ...

The other two licenses were awarded to New York Mets owner Steve Cohen with partner Hard Rock International for an $8 billion casino project next to Citi Field in Queens, and to Genting Group’s ...

Investing.com -- Golden Matrix Group Inc (NASDAQ:GMGI) stock jumped 9.7% on Monday after the online gaming platform provider announced a planned leadership transition, with CEO Brian Goodman set to ...

Investing.com -- U.S. President Donald Trump emphasized the importance of Israel maintaining a "strong and true dialogue with Syria" on Monday. In a post on Truth Social, Trump expressed his continued ...

Beyond cloud, the bank pointed to a more subdued outlook for the company’s retail business. Citing Adobe data, Oppenheimer said holiday sales are forecast to grow 5% year over year, down from 9% in ...

According to the company, Crownpeak is expected to generate approximately $70 million in revenue for the current year and will be immediately EBITDA-accretive. The acquisition gives Rezolve access to ...

The company’s board approved the program, which will allow Fitell to repurchase up to $3 million of its ordinary shares over the next 24 months. The repurchases will be conducted through open market ...

Investing.com -- Nvidia (NASDAQ:NVDA) CEO Jensen Huang described China as a "bonus opportunity" for the company’s future growth during an interview on CNBC on Monday.

Investing.com -- Altimmune Inc (NASDAQ:ALT) stock dropped 6.3% on Monday after the company announced a leadership transition plan that will see CEO Vipin Garg step down effective January 1, 2026.

Investing.com -- Sutro Biopharma (NASDAQ:STRO) stock tumbled 6.6% on Monday after the clinical-stage oncology company announced plans for a 1-for-10 reverse stock split to regain compliance with ...